Senior Surgical Fellow (Cathedral Assistant) @ Vitebsk State Medical University, Department of Otorhinolaryngology
Maryna Kryshtopava's Education
Ghent University
Doctor of Philosophy (PhD) (Medical Clinical Sciences/Graduate Medical Studies)
2013 - 2017
Vitebsk State Medical University, Vitebsk Regional Hospital, Department of Otorhinolaryngology
Candidate of Medical Sciences Degree (Otorhinolaryngology)
2004 - 2008
Board Certification
Board certified specialist (Otorhinolaryngology)
2007 - 2007
Vitebsk State Medical University, Vitebsk Regional Hospital, Department of Otorhinolaryngology
Clinical Residency (Otorhinolaryngology)
2002 - 2004
Vitebsk State Medical University
Medical Doctor (M.D.) (General Medicine (the last year of MD is specialization in surgery))
1996 - 2002
Maryna Kryshtopava's Skills
Otorhinolaryngology
Immunotherapy, immunorehabilitation, immunotropic and antiallergic drugs
Neurolaryngology
Septorhinoplasty with graft or implant
Training medical students on Otorhinolaryngology Rotation
Clinical Trials
New surgical approaches and devices in otorhinolaryngology
Biopolymer materials
Modification of the biopolymer materials
Tissue engineering cartilage or bone grafts.
Maryna Kryshtopava's Summary
Maryna Kryshtopava, based in Ghent, BE, is currently a Head of otorhinolaryngology department at Vitebsk State Medical University, bringing experience from previous roles at Department Otorhinolaryngology, Vitebsk State Medical University, Ghent University and Vitebsk State Medical University, Department of Otorhinolaryngology. Maryna Kryshtopava holds a 2013 - 2017 Doctor of Philosophy (PhD) in Medical Clinical Sciences/Graduate Medical Studies @ Ghent University. With a robust skill set that includes Otorhinolaryngology, Immunotherapy, immunorehabilitation, immunotropic and antiallergic drugs, Neurolaryngology, Septorhinoplasty with graft or implant, Training medical students on Otorhinolaryngology Rotation and more, Maryna Kryshtopava contributes valuable insights to the industry. Maryna Kryshtopava has 2 emails on RocketReach.